<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03160781</url>
  </required_header>
  <id_info>
    <org_study_id>UCA-01-EC/13/ART</org_study_id>
    <nct_id>NCT03160781</nct_id>
  </id_info>
  <brief_title>Intraosseous PRP for Knee Osteoarthritis: Pilot Study</brief_title>
  <official_title>Pilot Study to Evaluate Combination of Intraosseous With Intra-articular Infiltrations of Plasma Rich in Growth Factors (PRGF®-Endoret®) in the Treatment of Knee Osteoarthritis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unidad de Cirugía Artroscópica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unidad de Cirugía Artroscópica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to assess a novel approach to treating severe knee osteoarthritis&#xD;
      by targeting synovialmembrane, superficial articular cartilage, synovial fluid, and&#xD;
      subchondral bone by combining intra-articular injections and intraosseous infiltrations of&#xD;
      platelet rich plasma.This study explored a new strategy consisting of intraosseous&#xD;
      infiltrations of platelet rich plasma into the subchondral bone in combination with the&#xD;
      conventional intra-articular injection in order to tackle several knee joint tissues&#xD;
      simultaneously.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 28, 2014</start_date>
  <completion_date type="Actual">January 10, 2015</completion_date>
  <primary_completion_date type="Actual">January 10, 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain according to KOOS scale at 6 months after treatment</measure>
    <time_frame>6 months</time_frame>
    <description>Pain according to KOOS scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms according to KOOS scale at 6 months after treatment</measure>
    <time_frame>6 months</time_frame>
    <description>According to KOOS scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function according to KOOS scale at 6 months after treatment</measure>
    <time_frame>6 months</time_frame>
    <description>According to KOOS scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sport Activity according to KOOS scale at 6 months after treatment</measure>
    <time_frame>6 months</time_frame>
    <description>According to KOOS scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QoL according to KOOS scale at 6 months after treatment</measure>
    <time_frame>6 months</time_frame>
    <description>According to KOOS scale</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Platelet Rich Plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combination of Intraarticular and Intraosseous Administraion of Platelet Rich Plasma</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Platelet Rich Plasma</intervention_name>
    <description>Combination of Intraosseous and Intraarticular Infiltration of Platelet Rich Plasma</description>
    <arm_group_label>Platelet Rich Plasma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients of both sexes aged 40 to 77 years.&#xD;
&#xD;
          -  Predominant internal tibiofemoral knee osteoarthritis.&#xD;
&#xD;
          -  Joint pain above 2.5 VAS points.&#xD;
&#xD;
          -  Radiographic severity degrees 3 and 4 according to Ahlbäck scale.&#xD;
&#xD;
          -  Values of body mass index between 20 and 33.&#xD;
&#xD;
          -  Possibility for observation during the follow-up period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Bilateral knee osteoarthritis which requires infiltration in both knees.&#xD;
&#xD;
          -  Values of body mass index &gt; 33.&#xD;
&#xD;
          -  Polyarticular disease diagnosed.&#xD;
&#xD;
          -  Severe mechanical deformity (diaphyseal varus of 4∘ and valgus of 16∘).&#xD;
&#xD;
          -  Arthroscopy in the last year prior to treatment.&#xD;
&#xD;
          -  Intra-articular infiltration of hyaluronic acid in the past 6 months.&#xD;
&#xD;
          -  Systemic autoimmune rheumatic disease (connective tissue diseases and systemic&#xD;
             necrotizing vasculitis).&#xD;
&#xD;
          -  Poorly controlled diabetes mellitus (glycosylated hemoglobin above 9%).&#xD;
&#xD;
          -  Blood disorders (thrombopathy, thrombocytopenia, and anemia with Hb &lt; 9).&#xD;
&#xD;
          -  Undergoing immunosuppressive therapy and/or warfarin.&#xD;
&#xD;
          -  Treatment with corticosteroids during the 6 months prior to inclusion in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>77 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>May 17, 2017</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2017</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

